Immuneering Appoints Andrew Gengos as Chief Financial Officer
Go back to Immuneering Appoints Andrew Gengos as Chief Financial Officer| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 5.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.04 | 52 Week High | $0.04 | |||
| Open | $5.04 | 52 Week Low | $0.00 | |||
| Day High | $5.04 | P/E | N/A | |||
| Day Low | $5.04 | EPS | $-0.09 | |||
| Volume | 44 | |||||
